Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1[ALN-62643]----1件: 109 💬
2[RO7112689/F03-01]----1件: 109 💬
3[RO7112689/F03-10]----1件: 109 💬
4ALN-CC5----4件: 11, 62, 66, 109 💬
5ALXN1210----7件: 2, 11, 13, 50, 62, 66, 109 💬
6Anti-C5 antibody----4件: 11, 14, 62, 109 💬
7C5 inh MAb, SKY59, RO/CH7092230----2件: 62, 109 💬
8CCX168----6件: 43, 44, 49, 66, 109, 223 💬
9Cemdisiran1件: Cemdisiran---6件: 11, 15, 62, 66, 109, 223 💬
10COVERSIN----2件: 62, 109 💬
11Crovalimab1件: Crovalimab1件: Crovalimab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬3件: 48, 62, 109 💬
12CrovalimabProduct Code: RO7112689/F03-10Pharmaceutical Form: Solution for injection/infusionINN or Proposed INN: CROVALIMABCurrent Sponsor code: RO7112689Other descriptive name: C5 inh MAb, SKY59, RO/CH7092230Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 170-Product Name: CrovalimabProduct Code: RO7112689/F03-01Pharmaceutical Form: Solution for injection/infusionINN or Proposed INN: CROVALIMABCurrent Sponsor code: RO7112689Other descriptive name: C5 inh MAb, SKY59, RO/CH7092230Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 170-----1件: 109 💬
13ECULIZUMAB1件: Eculizumab1件: Eculizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬8件: 11, 13, 14, 61, 62, 109, 221, 223 💬
14Fc- and CDR-modified humanised monoclonal antibody against C5----3件: 11, 62, 109 💬
15IgG2/4?----1件: 109 💬
16Iptacopan1件: Iptacopan2件: Iptacopan ,
Iptacopan hydrochloride 💬 		1件: CFB 💬 3件: Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬8件: 11, 61, 62, 63, 66, 109, 222, 223 💬
17Iptacopan hydrochloride1件: Iptacopan2件: Iptacopan ,
Iptacopan hydrochloride 💬 		1件: CFB 💬 3件: Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬5件: 61, 63, 66, 109, 223 💬
18Iptcaopan 200 mg----1件: 109 💬
19LNP023----7件: 61, 62, 63, 66, 109, 222, 223 💬
20NM8074----5件: 50, 62, 66, 109, 223 💬
21OMS00620646, OMS620646, MASP-2 Antibody----1件: 109 💬
22OMS721----3件: 64, 66, 109 💬
23OMS721 100 mg/ml Injection solution, OMS00620646, OMS620646, MASP-2 Antibody----2件: 64, 109 💬
24OMS721 185 mg/ml Injection solution, OMS00620646, OMS620646, MASP-2 Antibody----2件: 64, 109 💬
25OMS721 Drug Product 185 mg/mL----1件: 109 💬
26Other: Blood sampling and urine analysis----1件: 109 💬
27Other: Eculizumab1件: Eculizumab1件: Eculizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 109 💬
28RAVULIZUMAB1件: Ravulizumab1件: Ravulizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬8件: 2, 11, 13, 50, 62, 66, 109, 224 💬
29RO7112689/F03-01----2件: 62, 109 💬
30RO7112689/F03-10----2件: 62, 109 💬
31RVA576----3件: 62, 109, 162 💬
32RVA576 (COVERSIN)----2件: 62, 109 💬
33Solaris----2件: 62, 109 💬
34SOLIRIS----6件: 11, 13, 14, 62, 109, 223 💬
35SOLIRIS - 300 MG CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO 1 FLACONCINO (VETRO) 30 ML (10 MG/ML)----3件: 13, 62, 109 💬
36SOLIRIS 300 mg concentrado para solución para perfusión----1件: 109 💬
37Soliris 300 mg solution à diluer pour perfusion----1件: 109 💬
38Ultomiris----7件: 2, 11, 13, 50, 62, 66, 109 💬
39 LNP023 HYDROCHLORIDE SALT----7件: 61, 62, 63, 66, 109, 222, 223 💬